‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective
Research Synthesis Methods · 2024
DOI: 10.1002/jrsm.1740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Synthesis Methods, 2024. Verfasst von Dan Jackson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Statistical Innovation Group, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
We respond to some of the methodological issues raised in a recent review of network meta‐analysis (NMA). We also provide a health technology developer's perspective and consider the future application of NMA to health technology assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Statistical Innovation Group, AstraZeneca, Cambridge, UK.
- Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, UK.
- Oncology Biometrics, AstraZeneca, Cambridge, UK.
ORCID-Profile: Dan Jackson, Landan Zhang
Zitieren
APA
Jackson, D., Zhang, L., Hettle, R., & Cooper, M. (2024). ‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective. Research Synthesis Methods. https://doi.org/10.1002/jrsm.1740
Vancouver
Jackson D, Zhang L, Hettle R, Cooper M. ‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective. Research Synthesis Methods. 2024. doi:10.1002/jrsm.1740
BibTeX
@article{Jackson2024,
author = {Jackson, Dan and Zhang, Landan and Hettle, Robert and Cooper, Miranda},
title = {‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective},
journal = {Research Synthesis Methods},
year = {2024},
doi = {10.1002/jrsm.1740}
}
EUVIMED